The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis - Archive ouverte HAL Access content directly
Journal Articles Microbiome Year : 2022

The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis

, , , (1) , ,
1
Laura Cox
  • Function : Author
Narghes Calcagno
  • Function : Author
Christian Gauthier
  • Function : Author
Oleg Butovsky
  • Function : Author
Howard Weiner
  • Function : Author

Abstract

Abstract Background The gut microbiota can affect neurologic disease by shaping microglia, the primary immune cell in the central nervous system (CNS). While antibiotics improve models of Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and the C9orf72 model of amyotrophic lateral sclerosis (ALS), antibiotics worsen disease progression the in SOD1 G93A model of ALS. In ALS, microglia transition from a homeostatic to a neurodegenerative (MGnD) phenotype and contribute to disease pathogenesis, but whether this switch can be affected by the microbiota has not been investigated. Results In this short report , we found that a low-dose antibiotic treatment worsened motor function and decreased survival in the SOD1 mice, which is consistent with studies using high-dose antibiotics. We also found that co-housing SOD1 mice with wildtype mice had no effect on disease progression. We investigated changes in the microbiome and found that antibiotics reduced Akkermansia and butyrate-producing bacteria, which may be beneficial in ALS, and cohousing had little effect on the microbiome. To investigate changes in CNS resident immune cells, we sorted spinal cord microglia and found that antibiotics downregulated homeostatic genes and increased neurodegenerative disease genes in SOD1 mice. Furthermore, antibiotic-induced changes in microglia preceded changes in motor function, suggesting that this may be contributing to disease progression. Conclusions Our findings suggest that the microbiota play a protective role in the SOD1 model of ALS by restraining MGnD microglia, which is opposite to other neurologic disease models, and sheds new light on the importance of disease-specific interactions between microbiota and microglia.

Dates and versions

hal-03704618 , version 1 (25-06-2022)

Identifiers

Cite

Laura Cox, Narghes Calcagno, Christian Gauthier, Charlotte Madore, Oleg Butovsky, et al.. The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis. Microbiome, 2022, 10 (1), pp.47. ⟨10.1186/s40168-022-01232-z⟩. ⟨hal-03704618⟩

Collections

INRAE
13 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More